Sunshine Biopharma, Inc. (SBFM)
Market Cap | 17.98M |
Revenue (ttm) | 490,878 |
Net Income (ttm) | -2.57M |
Shares Out | 22.59M |
EPS (ttm) | -5.07 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 35,857 |
Open | 0.770 |
Previous Close | 0.790 |
Day's Range | 0.770 - 0.807 |
52-Week Range | 0.620 - 9.870 |
Beta | -0.87 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Mar 27, 2023 |
About SBFM
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatmen... [Read more]
Full Company ProfileFinancial Performance
In 2021, SBFM's revenue was $228,426, an increase of 219.88% compared to the previous year's $71,410. Losses were -$12.44 million, 346.7% more than in 2020.
Financial StatementsNews

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment
MONTREAL, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includin...

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound
MONTREAL, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includin...

Sunshine Biopharma Announces Share Repurchase Program
MONTREAL, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includin...

Sunshine Biopharma's Annual Letter to Shareholders
MONTREAL, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includin...

4 Stocks Meeting GuruFocus' Value Screens in December
As investors prepare for the holiday season, GuruFocus' value screeners identified several stocks that meet screening criteria based on key principles taught by Benjamin Graham, Peter Lynch and Berksh...

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project
MONTREAL, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas, includi...

Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
MONTREAL, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drug...

Sunshine Biopharma Files Its Second Quarter Report With the SEC
Company Reports Significant Increase in Cash on Hand as a Result of Recent Financings Company Reports Significant Increase in Cash on Hand as a Result of Recent Financings

Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona
MONTREAL, July 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development an...

Sunshine Biopharma: An Opportunity Knocking?
Investors with a very high appetite for risk and seeking ultra-high-growth stocks can find potential opportunities within the pharma and biotech domain. Investing in development-stage biopharma compan...

Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market
MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, developmen...

Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM)
NEW YORK, NY / ACCESSWIRE / April 28, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ:SBFM) ...

Multiple Promising Treatments Accentuate the Bull Case for Sunshine Biopharma
SBFM stock is trading at a surprisingly low price, considering Sunshine Biopharma's demonstrably positive clinical results. The post Multiple Promising Treatments Accentuate the Bull Case for Sunshine...

Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market
MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, developmen...

Why Is Sunshine Biopharma (SBFM) Stock Up Today?
Today, investors in Sunshine Biopharma and SBFM stock are getting a huge boost from news that the company filed a patent for a key drug. The post Why Is Sunshine Biopharma (SBFM) Stock Up Today?

Why Sunshine Biopharma Stock Is Surging
Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading higher Monday after the company announced it filed a United States provisional patent application covering the recently communicated mRNA molec...

Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells
MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and ...

Blockbuster Clinical Results Shine a Positive Light on Sunshine Biopharma
An SEC filing may have deterred some traders from holding SBFM stock. However, a closer look at the facts should clear up any confusion.
5 Stocks Halted In Tuesday's Session
A circuit breaker is an automatic, temporary trading halt on specific securities when the underlying stock is experiencing times of high volatility. It is a measure to help restore and bring order to ...

Why Is Sunshine Biopharma (SBFM) Stock Down 30% Today?
Sunshine Biopharma's winning streak is likely finished due to confusion over an announcement. Here's why SBFM stock is down today.

Why Sunshine Biopharma Stock Is Falling Today
Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading lower Friday morning after the company announced a common stock offering. Sunshine Biopharma plans to offer on a resale basis an aggregate of ...

What's Going On With Sunshine Biopharma Stock Today?
Sunshine Biopharma Inc (NASDAQ: SBFM) is trading higher Wednesday on continued momentum after the company on Tuesday announced that two of its designed mRNA molecules are effective at destroying cance...

Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results
Montreal-based Sunshine Biopharma stock tripled to $6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells. The post Sunshine Biopharma ...

Sunshine Biopharma Shares Are Soaring: Here's Why
Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading significantly higher Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown...

Sunshine Biopharma's Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments